Good afternoon, good people, Ohm, you raise the ultimate

New Post Public Reply Private Reply Replies (0) Message Board
TSOV ohm20 #91307
763
Good afternoon, good people,

Ohm, you raise the ultimate question that can be asked of this entire fiasco called "FDA management and response of and to COVID-19". To wit: "if ordinary citizens don't hold the government accountable then who will?"

This is the ONLY question that matters at the moment- to shareholders, citizens of the United States, and suffering patients of COVID-19 the world over. Most everyone following Cytodyn and LL by now 'knows' 3 key pieces of information that are as irrefutable as irrefutable can get:

1. The drug is extremely safe and poses little to no harm
2. The drug has shown "benefit" in a particulary vulnerable subset of critical COVID-19 patients whom for which there is currently NO AVAILABLE approved therapeutic ANYWHERE
3. The FDA did NOT allow a 4 dose regimen as the company and its medical officers REQUESTED and was instead guided to an allowed only a 2 dose regimen that ended at day 14. Gilead and Lilly suffered no such restrictions that the public has been made aware of

These 3 pieces of information are not just damning to the ongoing credibility of the FDA but call into question whether or not the FDA has committed malfeasance. This term (malfeasance) is not one I use lightly but 'if the cap fits, then let them wear it'. (Hat tip The Legend, Bob Marley)

Therefore, Ohm, your question is THE question.

A wise man once said, if you want to get to the bottom of things "follow the money". Look who benefitted from keeping LL off the market. Then, look who agented that action. The FDA made no such effort to rebuke or reprise the makers of hydroxychloroquine, nor companies such a Gilead nor Eli Lilly, whose drugs proved woefully ineffectual and in some cases proved injurious to those taking them. This leads to one undeniable conclusion: the FDA is (has been) severely compromised during this year and half sojourn in all matters COVID-19. By whom and for whom is not my concern, the point is the agency can no longer be trusted to do its job. Our government is built on a series of checks and balances, with the ultimate check being the people and our right to vote and discuss amongst ourselves FREELY via our FREE speech within FREE assembly or within a FREE PRESS.

Let us for the sake of argument (of which this board heavily traffics) posit that via kleptocracy or sheer regulatory capture the FDA no longer suffers under the burdens of normal constitutional checks and balances, then what relief if any does Cytodyn and LL have?

Good people, let me share with you the marvel of 21st century Ameican style unfettered capitalism's most ingenious if not corrosive product: The Market.

The Market is our ultimate salve and imho the answer to Ohm's ultimate question. We are a public company whose shares are everyday FOR SALE on the open market even if our only product is not. This morning we learn that Pfizer and ...drumroll please ... AstraZenca's vaccines have proven effective against the Indian strain of COVID-19. This is a SIGNIFICANT development because we now have the possible entrant of a NON US BASED behemoth of a rival to the 2 US based duopolists of the SOC COVID-19 vaccination. Will Astra Zenca sit idly by and watch the defecto primary COVID-19 theraputic go unexploited? Will Merck sit idly and dump billions more into R&D while batting .000 thus far in the great game of International COVID-19 moneyball???

Our Top Line CD12 report is now public record.
This came AFTER the FDA's public puke on Cytodyn.

Imho, the only question that really remains after this last week and this morning's India AstraZeneca news is "how much?" and is that in "cash or stock"?

The FDA is big, yes but no entity, not even sovereign nations, are bigger than The Market.

The FDA has signaled to the entire table just how weak a hand they have had and it's my opinion that weak play is ALWAYS punished. That's why billionaires are billionaires and why bureaucrats are bureaucrats and why politicians tend to remain politicians. Water finds its appropriate level, much like talent in The Market.

TSOV
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 7

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 6

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 11

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 7

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading

Top 5 Most Recently Viewed Articles

HKUST Foundation Gala Dinner: A New Era of Innovation Begins

Updated Category News Views 213

HKUST Foundation Gala Dinner Fuels Future Innovation The inaugural Gala Dinner organized by the Hong Kong University of Science and Technology (HKUST) marked a significant milestone, uniting over 200 notable leaders from various sectors including academia, industry, and philanthropy. This prestigious event was held recently to celebrate the introduction of the HKUST...

Continue Reading
Univest Financial Posts Strong Q3 Performance Amid Market Challenges

Updated Category News Views 63

Univest Financial Corporation Reports Positive Third Quarter Results Univest Financial Corporation (UVSP) has announced a net income of $18.6 million for the recent quarter, translating to earnings of $0.63 per share. This performance is a testament to the company's effective management and strategic focus, especially in a challenging financial environment. The increase...

Continue Reading
Empowering Women’s Fitness: The Top Protein Powders for 2025

Updated Category News Views 298

Revolutionizing Women’s Fitness with Protein Powder Protein powders have recently transformed from a stereotypical gym supplement into a versatile health product embraced by women everywhere. These powders are now regarded as effective tools for weight loss, muscle building, and overall health improvement, making them a must-have for every woman looking to enhance her...

Continue Reading
Northeast Bank's Impressive Second Quarter Performance

Updated Category News Views 135

Overview of Second Quarter Results Northeast Bank (NASDAQ: NBN), a full-service financial institution based in Maine, recently disclosed its remarkable performance for the quarter that concluded on December 31, 2024. The Bank reported a net income of $22.4 million, translating to $2.74 per diluted common share. This marks a considerable increase from $14.1 million, or...

Continue Reading
Occidental Petroleum Affects Market with Price Declines

Updated Category News Views 44

Occidental Petroleum faced a significant downturn back in Q3 2024, reporting nearly a 6% drop in total oil output prices. This wasn't just bad luck; it was tied directly to global worries about oil demand growth that had traders fuming. Desks were already buzzing about how these price slides could shake up their earnings forecasts. Oil and Gas Price Plunge: What Went...

Continue Reading